MIMIVAX Trademark

Trademark Overview

On Tuesday, September 29, 2015, a trademark application was filed for MIMIVAX with the United States Patent and Trademark Office. The USPTO has given the MIMIVAX trademark a serial number of 86771918. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2019. This trademark is owned by MimiVax, LLC. The MIMIVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals for the prevention and treatment of cancer
mimivax

General Information

Serial Number86771918
Word MarkMIMIVAX
Filing DateTuesday, September 29, 2015
Status700 - REGISTERED
Status DateTuesday, June 11, 2019
Registration Number5775811
Registration DateTuesday, June 11, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2016

Trademark Statements

Goods and ServicesResearch and development of pharmaceuticals for the prevention and treatment of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 5, 2015
Primary Code042
First Use Anywhere DateMonday, August 22, 2011
First Use In Commerce DateMonday, August 22, 2011

Trademark Owner History

Party NameMimiVax, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBuffalo, NY 14263
Party NameMimiVax, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBuffalo, NY 14263
Party NameMimiVax, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBuffalo, NY 14263

Trademark Events

Event DateEvent Description
Tuesday, January 19, 2016ASSIGNED TO EXAMINER
Friday, October 2, 2015NEW APPLICATION ENTERED
Monday, October 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2016PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 25, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 3, 2016SOU TEAS EXTENSION RECEIVED
Thursday, November 3, 2016SOU EXTENSION 1 FILED
Thursday, November 3, 2016SOU EXTENSION 1 GRANTED
Saturday, November 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 10, 2017SOU TEAS EXTENSION RECEIVED
Monday, April 10, 2017SOU EXTENSION 2 FILED
Monday, April 10, 2017SOU EXTENSION 2 GRANTED
Wednesday, April 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2017SOU EXTENSION 3 FILED
Tuesday, October 10, 2017SOU EXTENSION 3 GRANTED
Thursday, October 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 12, 2018SOU TEAS EXTENSION RECEIVED
Thursday, April 12, 2018SOU EXTENSION 4 FILED
Thursday, April 12, 2018SOU EXTENSION 4 GRANTED
Saturday, April 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 26, 2018SOU TEAS EXTENSION RECEIVED
Friday, October 26, 2018SOU EXTENSION 5 FILED
Monday, November 5, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 5, 2018SOU EXTENSION 5 GRANTED
Tuesday, November 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2019TEAS STATEMENT OF USE RECEIVED
Monday, April 15, 2019USE AMENDMENT FILED
Wednesday, April 17, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, May 6, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 7, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 11, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, October 17, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 11, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

mimivax treatment cancer prevention pharmaceuticals development research